Teva Pharma (TEVA) Announces US Approval of a Generic Version of Forteo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 39.18 +0.05 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.13 | 52 Week High | $66.55 | |||
| Open | $38.92 | 52 Week Low | $37.82 | |||
| Day High | $39.39 | P/E | N/A | |||
| Day Low | $38.65 | EPS | $0.00 | |||
| Volume | 3,455,523 | |||||
